Crossmark Global Holdings, Inc. Qiagen N.V. Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$35.55 - $43.57 $250,485 - $306,994	-7,046 Reduced 9.71%	65,520 $2.85 Million
Q3 2023 Nov 08, 2023	BUY	$39.13 - $47.24 $3,991 - $4,818	102 Added 0.14%	72,566 $2.93 Million
Q2 2023 Jul 31, 2023	SELL	$43.93 - $46.76 $491,005 - $522,636	-11,177 Reduced 13.36%	72,464 $3.41 Million
Q1 2023 May 12, 2023	BUY	$45.29 - $50.76 $1.27 Million - $1.42 Million	28,053 Added 50.47%	83,641 $3.84 Million
Q4 2022 Jan 19, 2023	BUY	$41.91 - $50.48 $242,407 - $291,976	5,784 Added 11.61%	55,588 $2.77 Million
Q3 2022 Nov 01, 2022	BUY	$40.9 - $50.42 $104,663 - $129,024	2,559 Added 5.42%	49,804 $2.06 Million
Q2 2022 Jul 29, 2022	SELL	$42.98 - $49.77 $53,295 - $61,714	-1,240 Reduced 2.56%	47,245 $2.23 Million
Q1 2022 May 11, 2022	BUY	$42.23 - $54.3 $301,099 - $387,159	7,130 Added 17.24%	48,485 $2.38 Million
Q4 2021 Jan 10, 2022	BUY	$50.62 - $56.47 $588,710 - $656,746	11,630 Added 39.13%	41,355 $2.3 Million
Q3 2021 Oct 21, 2021	BUY	$46.55 - $56.83 $1.38 Million - $1.69 Million	29,725 New	29,725 $1.54 Million
Q3 2021 Oct 13, 2021	SELL	$46.55 - $56.83 $1.38 Million - $1.68 Million	-29,605 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$46.28 - $52.75 $23,602 - $26,902	-510 Reduced 1.69%	29,605 $1.43 Million
Q1 2021 Apr 15, 2021	SELL	$46.25 - $56.02 $48,932 - $59,269	-1,058 Reduced 3.39%	30,115 $1.47 Million
Q4 2020 Jan 14, 2021	SELL	$46.09 - $54.74 $26,732 - $31,749	-580 Reduced 1.83%	31,173 $1.65 Million
Q3 2020 Oct 08, 2020	SELL	$42.51 - $52.42 $121,153 - $149,397	-2,850 Reduced 8.24%	31,753 $1.66 Million
Q2 2020 Aug 14, 2020	BUY	$39.49 - $44.36 $262,529 - $294,905	6,648 Added 23.78%	34,603 $1.48 Million
Q1 2020 Apr 28, 2020	BUY	$33.17 - $41.6 $90,885 - $113,984	2,740 Added 10.87%	27,955 $1.16 Million
Q4 2019 Feb 06, 2020	SELL	$25.41 - $43.1 $476,945 - $808,987	-18,770 Reduced 42.67%	25,215 $852,000
Q3 2019 Oct 09, 2019	SELL	$32.73 - $40.81 $88,763 - $110,676	-2,712 Reduced 5.81%	43,985 $1.45 Million
Q2 2019 Jul 09, 2019	SELL	$35.73 - $41.39 $73,532 - $85,180	-2,058 Reduced 4.22%	46,697 $1.89 Million
Q1 2019 May 02, 2019	SELL	$33.78 - $40.68 $247,134 - $297,614	-7,316 Reduced 13.05%	48,755 $1.98 Million
Q4 2018 Jan 31, 2019	SELL	$32.65 - $37.95 $205,890 - $239,312	-6,306 Reduced 10.11%	56,071 $1.93 Million
Q3 2018 Nov 08, 2018	BUY	$35.99 - $39.39 $178,006 - $194,822	4,946 Added 8.61%	62,377 $2.36 Million
Q2 2018 Jul 31, 2018	SELL	$31.23 - $37.47 $252,026 - $302,382	-8,070 Reduced 12.32%	57,431 $2.08 Million
Q1 2018 Apr 16, 2018	SELL	$31.01 - $34.72 $351,839 - $393,933	-11,346 Reduced 14.76%	65,501 $2.12 Million
Q4 2017 Feb 05, 2018	SELL	$30.68 - $35.37 $191,013 - $220,213	-6,226 Reduced 7.49%	76,847 $2.38 Million
Q3 2016 Oct 25, 2017	BUY	N/A	83,073	83,073 $2.62 Million

Others Institutions Holding QGEN

# of Institutions

Shares Held

6.37M

Call Options Held

Put Options Held

Pendal Group LTD

4.3M
Shares

$198 Million
1.76% of portfolio
Abeille Asset Management Sa

931K
Shares

$42.9 Million
1.68% of portfolio
Grandeur Peak Global Advisors, LLC Salt Lake City, UT

796K
Shares

$36.7 Million
3.21% of portfolio
Pictet Asset Management Sa Geneva 73, V8

153K
Shares

$7.07 Million
0.01% of portfolio
Bdl Capital Management Paris, I0

88.8K
Shares

$4.09 Million
3.33% of portfolio

View Full List

About QIAGEN N.V.

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

More about QGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account